Voyager Therapeutics Inc
Price
$4.23
Today
-4.3%
YTD
+0.0%
Voyager Therapeutics Inc is a US-based clinical-stage biotechnology company focused on developing gene therapies for severe neurological diseases. Its primary aim is to create transformative treatments for patients with central nervous system disorders. Operating within the biotechnology sector, Voyager Therapeutics Inc uses adeno-associated virus (AAV) gene therapy technology to target the root causes of neurological conditions. The company’s global research initiatives strive to deliver long-lasting therapeutic benefits for conditions like Parkinson’s and ALS. Explore VYGR share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Valuation
Profitability
Earnings & Revenue
Dividends & Risk
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.